Graves Janessa M, Kanal Kalpana M, Vavilala Monica S, Applegate Kimberly E, Jarvik Jeffrey G, Rivara Frederick P
College of Nursing, Washington State University, Spokane, Washington; Harborview Injury Prevention and Research Center, University of Washington, Seattle, Washington; Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington.
Department of Radiology, School of Medicine, University of Washington, Seattle, Washington; Harborview Injury Prevention and Research Center, University of Washington, Seattle, Washington.
J Am Coll Radiol. 2014 Jul;11(7):717-724.e1. doi: 10.1016/j.jacr.2013.12.002.
To examine hospital-level factors associated with the use of a dedicated pediatric dose-reduction protocol and protective shielding for head CT in a national sample of hospitals.
A mixed-mode (online and paper) survey was administered to a stratified random sample of US community hospitals (N = 751). Respondents provided information on pediatric head CT scanning practices, including use of a dose-reduction protocol. Modified Poisson regression analyses describe the relative risk (RR) of not reporting the use of a pediatric dose-reduction protocol or protective shielding; multivariable analyses adjust for census region, trauma level, children's hospital status, and bed size.
Of hospitals that were contacted, 38 were ineligible (no CT scanner, hospital closed, do not scan infants), 1 refused, and 253 responded (35.5% response rate). Across all hospitals, 92.6% reported using a pediatric dose-reduction protocol. Modified Poisson regression showed that small hospitals (0-50 beds) were 20% less likely to report using a protocol than large hospitals (>150 beds) (RR: 0.80, 95% confidence interval [CI]: 0.65-0.99; adjusted for covariates). Teaching hospitals were more likely to report using a protocol (RR: 1.10, 95% CI: 1.02-1.19; adjusted for covariates). After adjusting for covariates, children's hospitals were significantly less likely to report using protective shielding than nonchildren's hospitals (RR: 0.64, 95% CI: 0.56-0.73), though this may be due to more advanced scanner type.
Results from this study provide guidance for tailored educational campaigns and quality improvement interventions to increase the adoption of pediatric dose-reduction efforts.
在全国医院样本中,研究与采用专门的儿科剂量降低方案及头部CT防护屏蔽相关的医院层面因素。
对美国社区医院的分层随机样本(N = 751)进行了混合模式(在线和纸质)调查。受访者提供了有关儿科头部CT扫描实践的信息,包括剂量降低方案的使用情况。修正泊松回归分析描述了未报告使用儿科剂量降低方案或防护屏蔽的相对风险(RR);多变量分析对人口普查区域、创伤级别、儿童医院状态和床位规模进行了调整。
在被联系的医院中,38家不符合条件(无CT扫描仪、医院关闭、不扫描婴儿),1家拒绝,253家做出回应(回应率35.5%)。在所有医院中,92.6%报告使用了儿科剂量降低方案。修正泊松回归显示,小型医院(0 - 50张床位)报告使用方案的可能性比大型医院(>150张床位)低20%(RR:0.80,95%置信区间[CI]:0.65 - 0.99;经协变量调整)。教学医院更有可能报告使用方案(RR:1.10,95% CI:1.02 - 1.19;经协变量调整)。在调整协变量后,儿童医院报告使用防护屏蔽的可能性显著低于非儿童医院(RR:0.64,95% CI:0.56 - 0.73),不过这可能是由于扫描仪类型更先进。
本研究结果为开展针对性的教育活动和质量改进干预措施提供了指导,以促进儿科剂量降低措施的采用。